Apeikon Therapeutics

Revolutionising oncology treatment with Apeikon Therapeutics’ image-guided activatables for effective and safer therapies.

Problem

Current oncology treatments impose significant side effects, compromising patients’ quality of life and placing a substantial economic burden on societies and healthcare systems.

Solution

Apeikon Therapeutics’ image-guided activatables offer a promising solution, providing more targeted and effective treatments that minimise side effects, enhance patients’ quality of life, and alleviate the economic strain on societies and healthcare systems.

Team

• Maya Thanou – CEO
• Maral Amrahli – COO

Website and social media

• Link
• LinkedIn

UN Sustainable Development Goals